Skip to main content

Table 1 Basic clinical characteristics of rs2241057 genotypes in the SCARF cohort.

From: A CYP26B1 Polymorphism Enhances Retinoic Acid Catabolism and May Aggravate Atherosclerosis

  

Homozygous for the major allele

Carriers of the minor allele

  

n

 

n

 

P

Age (years)

     
 

Patients

282

53.0 (49.0–57.0)

90

54.0 (48.8–57.0)

0.45

 

Controls

282

54.0 (49.8–57.0)

99

54.0 (49.0–57.0)

0.35

Body mass index (kg/m2)

     
 

Patients

281

26.8 (24.7–29.6)

90

26.6 (24.3–29.5)

0.70

 

Controls

282

25.6 (23.5–27.8)

98

25.7 (24.1–27.5)

0.79

Current smokers (%)

     
 

Patients

282

50.7

90

51.1

0.52

 

Controls

280

24.3

98

24.5

0.53

Serum cholesterol (mmol/L)

     
 

Patients

280

5.0 (4.2–5.7)

90

5.2 (4.5–5.7)

0.12

 

Controls

282

5.4 (4.8–6.1)

99

5.5 (4.7–6.2)

0.50

Serum low-density

     
 

lipoprotein (mmol/L) Patients

272

3.2 (2.5–3.9)

84

3.2 (2.6–3.9)

0.33

 

Controls

281

3.4 (2.9–4.1)

98

3.7 (3.0–4.3)

0.18

Serum high-density lipoprotein (mmol/L)

     
 

Patients

272

1.1 (0.9–1.4)

84

1.1 (0.9–1.4)

0.36

 

Controls

281

1.3 (1.1–1.7)

98

1.4 (1.1–1.6)

0.58

Serum triglycerides (mmol/L)

     
 

Patients

280

1.6 (1.2–2.2)

90

1.6 (1.2–2.3)

0.88

 

Controls

282

1.2 (0.86–1.6)

99

1.2 (0.82–1.5)

0.86

Blood CRP (mg/L)

     
 

Patients

272

1.39 (0.72–3.19)

88

2.01 (0.74–4.08)

0.18

 

Controls

275

0.93 (0.51–1.78)

98

1.04 (0.56–2.03)

0.35

  1. Values are medians (interquartile range) or percentage (%) as indicated. CRP C-reactive protein.